Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration.

C P Armstrong, A L Blower

Two hundred and thirty five consecutive patients with a life threatening complication of peptic ulceration, who either died or required emergency surgery, have been studied over a 36 month period. Seventy eight of these high risk patients died; 25 at home, 19 in hospital without surgery and 34 postoperatively. Ninety eight patients had bleeding ulcers, 132 perforated ulcers and five had both bleeding and perforated ulcers. One hundred and forty one of these 235 patients (60%) were taking a non-steroidal anti-inflammatory drugs (NSAID) and the individual agents have been listed. The overall incidence of NSAID use in a hospital control group was 9.9%. The first sign of an ulcer was a life threatening complication in 58.2% of patients taking a NSAID. Nearly 80% of all ulcer related deaths occurred in patients using an anti-inflammatory agent. Patients using these drugs were older, with more pre-existing medical conditions and had larger ulcers than those not taking NSAIDs. The mortality associated with a peptic ulcer complication in patients taking a NSAID was more than twice that in patients with no such drug history. There appears to be a relationship between the development of a life threatening complication of peptic ulceration and NSAID ingestion. Much of the associated mortality and morbidity may be potentially avoidable.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Brassard, R. (2007). Adverse Events in the Manipulation of Pediatric Patients: Flaws in a Systematic Review. Pediatrics 119: 1265-1266 [Full Text]  
• Mollace, V., Muscoli, C., Masini, E., Cuzzocrea, S., Salvemini, D. (2005). Modulation of Prostaglandin Biosynthesis by Nitric Oxide and Nitric Oxide Donors. Pharmacol. Rev. 57: 217-252 [Abstract] [Full Text]  
• Garcia Rodriguez, L. A., Hernandez-Diaz, S. (2004). Risk of Uncomplicated Peptic Ulcer among Users of Aspirin and Nonaspirin Nonsteroidal Antiinflammatory Drugs. Am J Epidemiol 159: 23-31 [Abstract] [Full Text]  
• Frezza, M, Gorji, N, Melato, M (2001). The histopathology of non-steroidal anti-inflammatory drug induced gastroduodenal damage: correlation with Helicobacter pylori, ulcers, and haemorrhagic events. J. Clin. Pathol. 54: 521-525 [Abstract] [Full Text]  
• Shah, A A, Thjodleifsson, B, Murray, F E, Kay, E, Barry, M, Sigthorsson, G, Gudjonsson, H, Oddsson, E, Price, A B, Fitzgerald, D J, Bjarnason, I (2001). Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen. Gut 48: 339-346 [Abstract] [Full Text]  
• Barnett, K., Bell, C. J., McKnight, W., Dicay, M., Sharkey, K. A., Wallace, J. L. (2000). Role of cyclooxygenase-2 in modulating gastric acid secretion in the normal and inflamed rat stomach. Am. J. Physiol. Gastrointest. Liver Physiol. 279: G1292-G1297 [Abstract] [Full Text]  
• Masferrer, J. L., Needleman, P. (2000). Anti-inflammatories for cardiovascular disease. Proc. Natl. Acad. Sci. USA 10.1073/pnas.240459597v1 [Full Text]  
• Watson, D. J., Harper, S. E., Zhao, P.-L., Quan, H., Bolognese, J. A., Simon, T. J. (2000). Gastrointestinal Tolerability of the Selective Cyclooxygenase-2 (COX-2) Inhibitor Rofecoxib Compared With Nonselective COX-1 and COX-2 Inhibitors in Osteoarthritis. Arch Intern Med 160: 2998-3003 [Abstract] [Full Text]  
• Huang, S. H.K. (2000). Rheumatology: 7. Basics of therapy. CMAJ 163: 417-423 [Full Text]  
• Tibble, J A, Sigthorsson, G, Foster, R, Scott, D, Fagerhol, M K, Roseth, A, Bjarnason, I (1999). High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut 45: 362-366 [Abstract] [Full Text]  
• Wolfe, M. M., Lichtenstein, D. R., Singh, G. (1999). Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs. NEJM 340: 1888-1899 [Full Text]  
• Sigthorsson, G, Tibble, J, Hayllar, J, Menzies, I, Macpherson, A, Moots, R, Scott, D, Gumpel, M J, Bjarnason, I (1998). Intestinal permeability and inflammation in patients on NSAIDs. Gut 43: 506-511 [Abstract] [Full Text]  
• Roth, S. H. (1996). NSAID Gastropathy: A New Understanding. Arch Intern Med 156: 1623-1628 [Abstract]  
• Griffin, M. R., Brandt, K. D., Liang, M. H., Pincus, T., Ray, W. A. (1995). Practical Management of Osteoarthritis: Integration of Pharmacologic and Nonpharmacologic Measures. Arch Fam Med 4: 1049-1055 [Abstract]  
• Laine, L., Peterson, W. L. (1994). Bleeding Peptic Ulcer. NEJM 331: 717-727 [Full Text]  
• Wilcox, C. M., Shalek, K. A., Cotsonis, G. (1994). Striking Prevalence of Over-the-Counter Nonsteroidal Anti-inflammatory Drug Use in Patients With Upper Gastrointestinal Hemorrhage. Arch Intern Med 154: 42-46 [Abstract]  
• Roth, S. H., Tindall, E. A., Jain, A. K., McMahon, F. G., April, P. A., Bockow, B. I., Cohen, S. B., Fleischmann, R. M. (1993). A Controlled Study Comparing the Effects of Nabumetone, Ibuprofen, and Ibuprofen Plus Misoprostol on the Upper Gastrointestinal Tract Mucosa. Arch Intern Med 153: 2565-2571 [Abstract]  
• Greene, J. M., Winickoff, R. N. (1992). Cost-Conscious Prescribing of Nonsteroidal Anti-inflammatory Drugs for Adults With Arthritis: A Review and Suggestions. Arch Intern Med 152: 1995-2002 [Abstract]  
• Cryer, B., Feldman, M. (1992). Effects of Nonsteroidal Anti-inflammatory Drugs on Endogenous Gastrointestinal Prostaglandins and Therapeutic Strategies for Prevention and Treatment of Nonsteroidal Anti-inflammatory Drug--Induced Damage. Arch Intern Med 152: 1145-1155 [Abstract]  
• Bollini, P., Rodriguez, L. A. G., Gutthann, S. P., Walker, A. M. (1992). The Impact of Research Quality and Study Design on Epidemiologic Estimates of the Effect of Nonsteroidal Anti-inflammatory Drugs on Upper Gastrointestinal Tract Disease. Arch Intern Med 152: 1289-1295 [Abstract]  
• Oyer, B., Lee, E., Feldman, M. (1992). Factors Influencing Gastroduodenal Mucosal Prostaglandin Concentrations: Roles of Smoking and Aging. ANN INTERN MED 116: 636-640 [Abstract]  
• Erstad, B. L., Neumayer, L. A. (1992). Massive Gastrointestinal Bleeding Associated With Ketorolac Administration. Journal of Pharmacy Practice 5: xi-xii  
• Gabriel, S. E., Jaakkimainen, L., Bombardier, C. (1991). Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs: A Meta-analysis. ANN INTERN MED 115: 787-796 [Abstract]  
• Agrawal, N. M., Roth, S., Graham, D. Y., White, R. H., Germain, B., Brown, J. A., Stromatt, S. C. (1991). Misoprostol Compared with Sucralfate in the Prevention of Nonsteroidal Anti-inflammatory Drug-induced Gastric Ulcer: A Randomized, Controlled Trial. ANN INTERN MED 115: 195-200 [Abstract]  
• Bliss, D. W., Stabile, B. E. (1991). The Impact of Ulcerogenic Drugs on Surgery for the Treatment of Peptic Ulcer Disease. Arch Surg 126: 609-612 [Abstract]  
• Griffin, M. R., Piper, J. M., Daugherty, J. R., Snowden, M., Ray, W. A. (1991). Nonsteroidal Anti-inflammatory Drug Use and Increased Risk for Peptic Ulcer Disease in Elderly Persons. ANN INTERN MED 114: 257-263 [Abstract]  
• Soll, A. H., Weinstein, W. M., Kurata, J., McCarthy, D. (1991). Nonsteroidal Anti-inflammatory Drugs and Peptic Ulcer Disease. ANN INTERN MED 114: 307-319 [Abstract]  
• Edelson, J. T., Tosteson, A. N. A., Sax, P. (1990). Cost-effectiveness of Misoprostol for Prophylaxis Against Nonsteroidal Anti-inflammatory Drug--Induced Gastrointestinal Tract Bleeding. JAMA 264: 41-47 [Abstract]  
• Hillman, A. L., Bloom, B. S. (1989). Economic Effects of Prophylactic Use of Misoprostol to Prevent Gastric Ulcer in Patients Taking Nonsteroidal Anti-inflammatory Drugs. Arch Intern Med 149: 2061-2065 [Abstract]  
• Masi, A. T. (1989). Nonsteroidal Anti-Inflammatory Drugs and Peptic Ulcer. ANN INTERN MED 110: 246-247 [Abstract]  
• Itokazu, G. S., Danziger, L. H. (1989). Therapeutic Drug Monitoring in Patients With Ulcers. Journal of Pharmacy Practice 2: 382-392  
• Griffin, M. R., Ray, W. A., Schaffner, W. (1988). Nonsteroidal Anti-Inflammatory Drug Use and Death from Peptic Ulcer in Elderly Persons. ANN INTERN MED 109: 359-363 [Abstract]  
• Masferrer, J. L., Needleman, P. (2000). Anti-inflammatories for cardiovascular disease. Proc. Natl. Acad. Sci. USA 97: 12400-12401 [Full Text]